128 related articles for article (PubMed ID: 4005957)
1. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.
Lala PK; Santer V; Libenson H; Parhar RS
Cell Immunol; 1985 Jul; 93(2):250-64. PubMed ID: 4005957
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
3. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity.
Parhar RS; Lala PK
Cell Immunol; 1985 Jul; 93(2):265-79. PubMed ID: 3159480
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the maternal natural killer cell population during the course of murine pregnancy.
Chatterjee-Hasrouni S; Parhar R; Lala PK
Cell Immunol; 1984 Apr; 84(2):264-75. PubMed ID: 6705050
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lymphocyte subsets in spontaneous mouse mammary tumors and host lymphoid organs.
Santer V; Mastromarino JH; Lala PK
Int J Cancer; 1980 Jan; 25(1):159-68. PubMed ID: 6967460
[TBL] [Abstract][Full Text] [Related]
7. Changes in the populations of null, NK1.1+, and Thy1lo lymphocytes in the bone marrow of tumor-bearing mice: effect of indomethacin treatment.
Rahal MD; Reinish E; Osmond DG
Cell Immunol; 1992 Jan; 139(1):218-28. PubMed ID: 1345896
[TBL] [Abstract][Full Text] [Related]
8. Effects of tumor bearing on the dynamics of host hemopoietic cells.
Lala PK
Cancer Treat Rep; 1976 Dec; 60(12):1781-9. PubMed ID: 1026335
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Khoo NK; Chan FP; Saarloos MN; Lala PK
Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin-mediated inactivation of natural killer cells in the murine decidua.
Scodras JM; Parhar RS; Kennedy TG; Lala PK
Cell Immunol; 1990 May; 127(2):352-67. PubMed ID: 2139365
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells in murine muscular dystrophy. IV. Characterization of Percoll fractionated splenic and thymic natural killer cells and natural killer-sensitive thymocyte targets.
Semple JW; Szewczuk MR
Clin Immunol Immunopathol; 1986 Oct; 41(1):116-29. PubMed ID: 3017622
[TBL] [Abstract][Full Text] [Related]
12. Enhanced natural killer (NK) cell activity and NK-sensitive thymic cells in murine muscular dystrophy.
Semple JW; Szewczuk MR
Cell Immunol; 1983 Dec; 82(2):316-25. PubMed ID: 6652689
[TBL] [Abstract][Full Text] [Related]
13. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
14. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
Vujanovic NL; Herberman RB; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
[TBL] [Abstract][Full Text] [Related]
15. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
16. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
Kumar V; Luevano E; Bennett M
J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
[TBL] [Abstract][Full Text] [Related]
17. Quantitative studies of natural immunity to solid tumours in rats. NK activity in animals with primary or transplanted spontaneous tumours.
Flannery GR; Brooks CG
Int J Cancer; 1981 Dec; 28(6):747-55. PubMed ID: 7333706
[TBL] [Abstract][Full Text] [Related]
18. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
[TBL] [Abstract][Full Text] [Related]
19. An analysis of host T-cell subsets based on Lyt antigenic markers during the development of spontaneous C3H mammary carcinomas.
Brodt P; Lala PK
Cell Immunol; 1984 Apr; 84(2):427-32. PubMed ID: 6608412
[TBL] [Abstract][Full Text] [Related]
20. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
